To combat the outbreak, Nigeria has received 10,000 vaccine doses from the United States and has implemented a health declaration form for international travelers. Meanwhile, the African Union has declared a public health emergency due to the rapid spread of the virus on the continent.

Monkeypox, transmitted through close contact with infected individuals or contaminated objects, can cause symptoms such as fever, body aches, swollen lymph nodes, and skin lesions. While most cases are mild, antiviral drugs can be used to manage severe symptoms.

The World Health Organization (WHO) is working to increase vaccine access to affected countries, but the supply remains limited. Health authorities in Africa estimate that they need around 380,000 vaccine doses to end the outbreaks, but the current supply falls far short of this requirement.

Experts are emphasizing the need for more research to understand mpox transmission in Africa and optimize vaccine use. As the number of cases continues to rise, efforts to contain the outbreak and protect public health remain crucial. (ILKHA)